114 results
Page 5 of 6
S-3ASR
b2m7pf3bir
23 Jul 19
Automatic shelf registration
4:52pm
8-K
EX-99.1
j7drr3wlkug qpgtz
6 Jun 19
Other Events
7:05am
8-K
EX-99.2
3frjw
6 Jun 19
Other Events
7:05am
8-K
EX-99.1
arysrpk
9 May 19
Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update
7:05am
8-K
EX-10.1
pdjgcsw9mhp4ba
6 May 19
Athenex Announces $100 Million Private Placement
8:06am
8-K
EX-99.1
hxsxzj6o
21 Mar 19
Athenex Announces Expansion of Board of Directors
8:46am
8-K
EX-99.1
4cvgdi
11 Mar 19
Positive Phase III topline results ofKX2-391 in actinic keratosis featured in late breaker session at recent 2019 AAD Annual Meeting
7:30am
8-K
EX-99.1
9llu1bmh3mu36w1otnss
4 Mar 19
Regulation FD Disclosure
7:00am
8-K
EX-10.1
t11pcwidczu
3 Jan 19
Chongqing Jingdong Pharmaceutical and Athenex announce a strategic partnership and licensing agreement to develop and commercializeKX2-391 in China
7:00am
8-K
EX-10.2
07m52h jj4ac
3 Jan 19
Chongqing Jingdong Pharmaceutical and Athenex announce a strategic partnership and licensing agreement to develop and commercializeKX2-391 in China
7:00am
8-K
EX-99.1
b09v kvg528rx
17 Dec 18
Regulation FD Disclosure
7:01am
8-K
EX-99.1
wnvg66oly6 5hv
4 Dec 18
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
5:17pm
8-K
EX-99.1
6rwq8mwdndn
14 Nov 18
Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update
7:00am
8-K
EX-99.1
xwv330ym2tpunk1km
22 Oct 18
Regulation FD Disclosure
7:09am
8-K
s0qq9 x11n0dhr89k
22 Oct 18
Regulation FD Disclosure
7:09am